Lakefront Biotherapeutics NV (LKFT)
NASDAQ: LKFT · Real-Time Price · USD
28.80
+0.53 (1.87%)
At close: Aug 21, 2026, 4:00 PM EDT
28.78
-0.02 (-0.07%)
After-hours: Aug 21, 2026, 7:30 PM EDT
Lakefront Biotherapeutics NV Employees
Lakefront Biotherapeutics NV had 452 employees as of December 31, 2025. The number of employees decreased by 252 or -35.80% compared to the previous year.
Employees
452
Change (1Y)
-252
Growth (1Y)
-35.80%
Revenue / Employee
$2,503,753
Profits / Employee
$1,508,044
Market Cap
1.89B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Recursion Pharmaceuticals | 600 |
| Immunocore Holdings | 524 |
| Syndax Pharmaceuticals | 298 |
| Kardigan | 241 |
| Zymeworks | 231 |
| Septerna | 123 |
| Taysha Gene Therapies | 99 |
| GH Research | 73 |
LKFT News
- 4 days ago - Acquisition of Own Shares - GlobeNewsWire
- 10 days ago - Acquisition of Own Shares - GlobeNewsWire
- 12 days ago - Lakefront Biotherapeutics price target lowered to $26 from $30 at Morgan Stanley - TheFly
- 12 days ago - Lakefront Biotherapeutics NV Earnings release: Q2 2026 - Filings
- 12 days ago - Lakefront Biotherapeutics NV Quarterly report: Q2 2026 - Filings
- 25 days ago - Acquisition of Own Shares - GlobeNewsWire
- 4 weeks ago - Acquisition of Own Shares - GlobeNewsWire
- 5 weeks ago - Acquisition of Own Shares - GlobeNewsWire